During the last session, Atyr Pharma Inc (NASDAQ:ATYR)’s traded shares were 2.5 million, with the beta value of the company hitting 0.95. At the end of the trading day, the stock’s price was $5.33, reflecting an intraday loss of -3.62% or -$0.2. The 52-week high for the ATYR share is $5.98, that puts it down -12.2 from that peak though still a striking 70.36% gain since the share price plummeted to a 52-week low of $1.58. The company’s market capitalization is $474.39M, and the average intraday trading volume over the past 10 days was 4.89 million shares, and the average trade volume was 2.32 million shares over the past three months.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Atyr Pharma Inc (ATYR) registered a -3.62% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -3.62% in intraday trading to $5.33, hitting a weekly high. The stock’s 5-day price performance is 0.95%, and it has moved by -2.20% in 30 days. Based on these gigs, the overall price performance for the year is 47.24%. The short interest in Atyr Pharma Inc (NASDAQ:ATYR) is 13.64 million shares and it means that shorts have 6.12 day(s) to cover.
Atyr Pharma Inc (ATYR) estimates and forecasts
In the rating firms’ projections, revenue will increase 2,685.30% compared to the previous financial year.
Meanwhile, a consensus of 11 analyst(s) estimates revenue growth to 1.09M by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 34.28%. While earnings are projected to return 28.86% in 2025.
ATYR Dividends
Atyr Pharma Inc is due to release its next quarterly earnings on 2025-May-07. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Atyr Pharma Inc (NASDAQ:ATYR)’s Major holders
Atyr Pharma Inc insiders own 2.23% of total outstanding shares while institutional holders control 69.63%, with the float percentage being 71.22%.
Also, the Mutual Funds coming in first place with the largest holdings of Atyr Pharma Inc (ATYR) shares are Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund and Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund . Data provided on Apr 30, 2025 indicates that Federated Hermes Equity Funds-Federated Hermes Kaufmann Fund owns about 7.85 shares. This amounts to just over 8.82 percent of the company’s overall shares, with a $41.84 million market value. The same data shows that the other fund manager holds slightly less at 6.62, or about 7.44% of the stock, which is worth about $35.28 million.
